U.S. Markets open in 7 hrs 7 mins

Global Hematologic Malignancies Testing Market to 2025: Focus on Product, Disease, Technology, End User, Region/Country Data and Competitive Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--

The "Global Hematologic Malignancies Testing Market: Focus on Product, Disease, Technology, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global hematologic malignancies testing market?
  • What are the underlying structures resulting in the emerging trends within the global hematologic malignancies testing market?
  • How is each segment expected to grow in the global hematologic malignancies testing market during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2025?
  • What are the key developmental strategies which are implemented by the major players in order to sustain in the competitive market? What are the key regulatory implications in developed and developing regions for hematologic malignancies testing?
  • Who are the leading players with significant offerings to the global hematologic malignancies testing market? What is the current market dominance for each of these leading players?
  • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2019-2025?
  • What are the key applications in the global hematologic malignancies testing market? What are the major segments of these applications?
  • Which are the dominant disease areas of the global hematologic malignancies testing market? Which is the fastest-growing disease area in the global hematologic malignancies testing market?
  • Who are the key manufacturers and service providers in the global hematologic malignancies testing market, and what are their contributions? What is the growth potential of each major hematologic malignancies testing solution provider?

Global Hematologic Malignancies Testing Market Forecast, 2019-2025

The hematologic malignancies testing market growth has been primarily attributed to the major drivers in this market such as rising incidence of hematologic malignancies, increasing adoption of inorganic growth strategies in the market, favorable reimbursement scenario in the global hematologic malignancies testing market, and increasing funding in hematologic malignancies testing market. However, there are significant challenges that are restraining the market growth. These challenges include high pricing pressure, lack of trained professionals, and issues pertaining to the analytical validity of genetic testing for cancers.

Scope of the Market Intelligence on Hematologic Malignancies Testing Market

The hematologic malignancies testing market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global hematologic malignancies testing market.

Key Topics Covered:

Executive Summary

1 Market Overview

1.1 Introduction

1.2 Historical Perspective

1.3 Types of Hematologic Malignancy Diagnostic Tests

1.4 Global Footprint

1.5 Trends and Future Potential

2 Market Dynamics

2.1 Market Drivers

2.1.1 Rising Incidence of Hematologic Malignancies

2.1.2 Increasing Adoption of Inorganic Growth Strategies in the Market

2.1.3 Favorable Reimbursement Scenario in the Global Hematologic Malignancies Testing Market

2.1.4 Increase in Funding in Hematologic Malignancies Testing Market

2.2 Restraints

2.2.1 High Pricing Pressure

2.2.2 Lack of Trained Professionals

2.2.3 Issues Pertaining to the Analytical Validity of Genetic Testing for Cancers

2.3 Market Opportunities

2.3.1 Opportunities in the Emerging Economies

2.3.2 Technological Advancements in the Field of Molecular Diagnostics

3 Competitive Landscape

3.1 Key Strategies and Developments

3.2 Product Scenario

3.3 Funding Scenario

3.4 Market Share Analysis

3.5 Growth Share Analysis (Opportunity Mapping)

3.6 Comprehensive Competitive Index

4 Industry Insights

4.1 Regulatory Framework

4.1.1 Legal Requirements and Framework in the U.S.

4.1.2 Legal Requirements and Framework in Europe

4.1.3 Legal Requirements and Framework in Asia-Pacific

4.1.3.1 Japan

4.1.3.2 China

4.2 Reimbursement Scenario

4.3 Physicians' Perceptions

5 Global Hematologic Malignancies Testing Market (by Product)

5.1 Services

5.2 Kits

5.2.1 Gene Panels

5.2.2 Molecular Clonality Testing

5.2.3 Translocation Testing

5.2.4 Mutation Testing

5.2.5 Minimal Residual Disease (MRD) Testing

6 Global Hematologic Malignancies Testing Market (by Disease)

6.1 Leukemia

6.2 Lymphoma

6.3 Multiple Myeloma

6.4 Myeloproliferative Neoplasms

6.5 Myelodysplastic Syndromes

7 Global Hematologic Malignancies Testing Market (by Technology)

7.1 Next-Generation Sequencing (NGS)

7.2 Polymerase Chain Reaction (PCR)

7.3 Fluorescence in Situ Hybridization (FISH)

7.4 Immunohistochemistry (IHC)

7.5 Flow Cytometry

7.6 Other Technologies

8 Global Hematologic Malignancies Testing Market (by End User)

8.1 Specialty Clinics and Hospitals

8.2 Diagnostic Laboratories

8.3 Reference Laboratories

8.4 Research Institutions

9 Global Hematologic Malignancies Testing Market (by Region)

10 Company Profiles

  • Abbott Laboratories
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • ASURAGEN, INC.
  • Cancer Genetics Inc.
  • QIAGEN N.V.
  • ArcherDX, Inc.
  • Adaptive Biotechnologies
  • ICON plc
  • Quest Diagnostics Incorporated
  • ARUP Laboratories
  • Invivoscribe, Inc.
  • NeoGenomics Laboratories, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/polq31

View source version on businesswire.com: https://www.businesswire.com/news/home/20191204005431/en/

  • Stocks Decline in Risk-Off Turn; Yen Rises: Markets Wrap
    World
    Bloomberg

    Stocks Decline in Risk-Off Turn; Yen Rises: Markets Wrap

    Seven straight weekly advances in the MSCI Asia Pacific Index might also have left some investors looking for a short-term exit point from equities. “As Chinese citizens travel home for the Lunar New Year, more cases of the new virus have been reported and it seems it is spreading,” said Zhou Hao, a senior emerging markets economist at Commerzbank AG. “There is a risk of an exponential outbreak” along the lines of the 2003 SARS virus, Zhou said.

  • U.S. Stock Index Futures Decline Amid China Virus Fears
    Business
    Bloomberg

    U.S. Stock Index Futures Decline Amid China Virus Fears

    U.S. stock index futures slid as concerns over the spread of a SARS-like virus from central China damped demand for equities. S&P 500 Index futures contracts expiring in March fell as much as 0.5% after multiple medical workers were reported to have been infected. Dow Jones Industrial Average contracts were down 0.3% while those on the Nasdaq 100 retreated 0.5%.

  • Business
    Bloomberg

    Peter Schiff Says He’s Lost His Bitcoin After Wallet Freeze-Out

    Cryptocurrency skeptic Peter Schiff said he can't access his Bitcoin holdings after his digital wallet stopped accepting his password. I just lost all the Bitcoin I have ever owned,” Schiff, chief global strategist at Alliance Global Partners, said in a series of posts on his unverified Twitter account. My wallet got corrupted somehow and my password is no longer valid.

  • 3 Top-Notch “Strong Buy” Stocks Under $3
    Business
    TipRanks

    3 Top-Notch “Strong Buy” Stocks Under $3

    If you're on a budget, yet in a risk-tolerant mood, it's worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here you get a lot more for your money; For example, buying a single share of Amazon will set you back $1,865, but if you wanted to spend the equivalent amount on a stock worth $3, you could load up on 621 shares of company x. Is it worth it though?

  • Bearish Bets: 2 Well-Known Stocks You Should Consider Shorting This Week
    Business
    TheStreet.com

    Bearish Bets: 2 Well-Known Stocks You Should Consider Shorting This Week

    Using recent actions and grades from TheStreet's Quant Ratings and layering on technical analysis of the charts of those stocks, Trifecta Stocks identifies five names each week that look bearish. While we will not be weighing in with fundamental analysis we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Nektar Therapeutics Inc. recently was downgraded to Sell with a D rating by TheStreet's Quant Ratings.

  • These 3 Software Stocks Can Climb Higher in 2020, Says Top Investing Firm
    Business
    TipRanks

    These 3 Software Stocks Can Climb Higher in 2020, Says Top Investing Firm

    Yes, the economy still runs on oil and coal, but digital technology has impacted all of us, whether we work in factories or offices or watch the kids at home. All of these factors make software companies a natural place for investors to look when they seek stocks with high return potential. Software companies create the code and programs that let us maneuver in the digital world, from messenger apps to word processing and facial recognition.

  • Value stocks are making a comeback, and here’s how to get in early
    Business
    MarketWatch

    Value stocks are making a comeback, and here’s how to get in early

    I believe that is unlikely to continue,” says Joel Greenblatt, the co-chief investment officer at Gotham Funds. was the worst year since 1999 for the strategy of buying cheap stocks and shorting expensive stocks (the top quintile for each), Greenblatt says. The last time this strategy experienced such extremely poor results, value put in three great years of performance, from 2000-2002.

  • Dow Jones Futures: Stock Market Rally Faces Next Test; Netflix, Texas Instruments Earnings Due
    Business
    Investor's Business Daily

    Dow Jones Futures: Stock Market Rally Faces Next Test; Netflix, Texas Instruments Earnings Due

    Dow Jones futures fell Monday night, along with S&P 500 futures and Nasdaq futures, with Asian markets selling off amidgrowing evidence that China's coronavirus can spread from human to human. The coronavirus is unexpected news. Earnings season is expected, but the outcome unclear.

  • What interest rates dating back to 1311 tell us about today’s global economy
    Business
    Quartz

    What interest rates dating back to 1311 tell us about today’s global economy

    Interest rates sure are weird these days. Five central banks currently hold policy rates negative; several are dabbling with unconventional bond-buying. The one bank that tried to raise them, the Federal Reserve, found itself back cutting rates within a year.

  • `Substantial' Market Correction Is Unlikely, Fidelity's Richards Says
    Business
    Bloomberg

    `Substantial' Market Correction Is Unlikely, Fidelity's Richards Says

    Anne Richards, chief executive officer of Fidelity International, discusses the outlook for the global economy, financial markets and active management in 2020. She speaks with Francine Lacqua on "Bloomberg Markets" at the World Economic Forum's annual meeting in Davos, Switzerland.

  • The ‘best job in America’ pays $105,000 — and you’ve probably never heard of it
    Business
    MarketWatch

    The ‘best job in America’ pays $105,000 — and you’ve probably never heard of it

    Front-end engineers had an average overall job satisfaction score of 3.9 out of 5 on Glassdoor, making theirs the No. 1 profession for 2020 in terms of job satisfaction, salary and job openings, according to a new ranking, knocking data scientists off the No 1 spot. Front-end engineers develop the code that enhances a customer's or user's experience, and essentially create, install and test the user interface elements of a website. Amanda Stansell, senior economic research analyst at Glassdoor, said there's more competition between tech and non-tech companies for these roles.

  • 3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside
    Business
    TipRanks

    3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside

    To watch Selvaraju's track record, click here) The Street appears equally confident in IMMU's future potential; 4 Buy ratings add up to a Strong Buy consensus rating. With an average price target of $28, the analysts believe Immunomedics can add 47% to its share price over the coming year. See Immunomedics stock analysis on TipRanks) Revance Therapeutics (RVNC) After a disappointing 2019, which saw Revance's share price drop by more than 18%, the neuromodulator-focused biotech has started 2020 with a bang; Revance stock is up by 38% year-to-date.

  • Pitt gets emotional after SAG win
    News
    Associated Press Videos

    Pitt gets emotional after SAG win

    Brad Pitt says he was moved by his win at the SAG Awards and muses on why "Once Upon a Time... in Hollywood" has struck a chord with so many people. Pitt took home Outstanding Performance by a Male Actor in a Supporting Role for his work in the movie.

  • Business
    TheStreet.com

    Is the Stock Market Open on Martin Luther King Jr. Day?

    Martin Luther King Jr. Day was first signed into law in 1983, and first officially observed as a holiday in 1986. Generally observed on the third Monday of January (close to or on King's actual birthday, January 15), MLK Day celebrates the life and legacy of one of America's most well-known and influential activists, who fought for racial and economic justice across the country. Martin Luther King Jr. Day, falling on January 20 this year, is a federal holiday, and not every worker in the country necessarily gets a day off of work for it (45% of employers gave workers the day off in 2019).

  • Avoid Paying Taxes on Social Security Income
    Business
    Investopedia

    Avoid Paying Taxes on Social Security Income

    With no inflation adjustment having been made to these benchmarks since 1983, they're now exceeded by most taxpayers who receive Social Security benefits and have other sources of income, too. A number of strategies, both before and after you retire, can limit the amount of tax you pay on Social Security benefits. Reducing your taxable income during the years in which you're drawing Social Security can have other benefits, too, such as lowering your Medicare premiums, which vary by income.

  • Head of Canada Pension Fund Warns on Rush to Iliquid Assets
    Business
    Bloomberg

    Head of Canada Pension Fund Warns on Rush to Iliquid Assets

    The biggest global funds should all be monitoring their investments in illiquid assets, according to the head of Canada's largest pension fund. I do ring the alarm bell on not to be too invested in illiquid assets,” Mark Machin, chief executive officer of the Canada Pension Plan Investment Board, said in a Bloomberg Television interview Monday at the World Economic Forum in Davos. We are very comfortable with our risk models and what we would do in various lurches down markets, but I do worry about the expansion of a lot of funds like us around the world into private illiquid assets.

  • Are 401(k) Withdrawals Considered Income?
    Business
    Investopedia

    Are 401(k) Withdrawals Considered Income?

    Starting at age 59½, retirement savers can start accessing their accounts without penalty. Moreover, at age 72, retirees are mandated to start taking required minimum distributions (RMDs). Here we look at what happens when you make those 401(k) withdrawals.

  • Business
    MoneyShow

    Top Picks 2020- Cisco Systems CSCO

    See also: Top Picks 2020: Bristol-Myers Squibb (BMY) Over the last few years, CSCO has set out to reinvent IT architectures to help customers simplify the ever-changing technology landscape. In doing so, they are focusing on six core elements: applications, data, security, cloud, infrastructure, and teams. These six core elements add value as more and more business migrate from an internal network structure to private, hybrid, and even multi-cloud environments.

  • Business
    Barrons.com

    A Contrarian Value Investor Bought Up AT&T Stock, Sold Apple, Microsoft and Amazon

    Contrarian value investor Tocqueville Asset Management in aggregate made some big changes to its overall investments in well-known large-cap stocks. Tocqueville bought substantially more (T) stock (ticker: T) in the fourth quarter, while slashing positions in (AAPL)(AAPL), (MSFT)(MSFT), and (AMZN) stock (AMZN). The firm disclosed the stock trades, among others, in a form it filed with the Securities and Exchange Commission.

  • Tesla Slams Acceleration Petition Brought by ‘Short Seller’
    Business
    Bloomberg

    Tesla Slams Acceleration Petition Brought by ‘Short Seller’

    The National Highway Traffic Safety Administration is evaluating allegations that Tesla Inc. vehicles contain a defect that can cause sudden unintended acceleration, according to a notice posted on the agency's website last week. The review was prompted by a petition asking the agency to open a defect investigation of some 500,000 Tesla vehicles over the alleged flaw. The petition cited 127 consumer complaints to the agency and claims of 110 crashes.

  • Business
    GuruFocus.com

    Marathon Petroleum and Auto Nation Are on the Casualty List

    Buying the stocks of good companies on bad news is my favorite investing method. The trick is to find bad news that is real but probably temporary. Each quarter in this column I compile my Casualty List.

  • 3 Monster Growth Stocks That Can Rip Higher in 2020
    Business
    TipRanks

    3 Monster Growth Stocks That Can Rip Higher in 2020

    The impressive share gains are bolstered by a strong financial performance. MTZ last reported earnings at the beginning of November, and easily beat the EPS forecasts and the year-ago numbers. For revenue, MTZ reported $2.02 billion, which missed the forecast but was still up 2% year-over-year.

  • Stock market is “eerily reminiscent of January 2018” when stocks suffered rapid correction, technical analyst says
    Business
    MarketWatch

    Stock market is “eerily reminiscent of January 2018” when stocks suffered rapid correction, technical analyst says

    Stock market investors could be setting themselves up for a nasty fall. “52-week highs, the percentage of issues above their 200-day moving average, and sector high all are suggesting bullish long-term momentum, but the crescendo nature of this strength without meaningful single day breadth figures and elevated complacency leaves us tactically cold,” he wrote in a Friday note.

  • Business
    Benzinga

    Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

    Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week Welcome to the Cannabis Countdown. In this week's rendition, we'll recap and countdown the top 10 marijuana stock news stories for the week of January 13th – 19th, 2020. Without further ado, let's get started.

  • The Benefits of Starting an IRA for Your Child
    Business
    Investopedia

    The Benefits of Starting an IRA for Your Child

    The primary difference between traditional and Roth IRAs is when you pay taxes on the money that you contribute to the plan. With a traditional IRA, you pay taxes when you withdraw the money during retirement (at your then-applicable tax rate). All the funds, both your contributions and any earnings they've accrued, are considered pre-tax in a traditional IRA.